The Federal Government has executed the 7th Community Pharmacy Agreement which will be in place for the next five years, which provides a period of certainty for Ebos Group and fellow pharmacy companies, the broker notes. Ebos provided many services and products that were in high demand during the crisis, and is well funded.

The broker makes no changes to forecasts and believes the company is well placed to grow in the medium term. Target falls to $24.58 from $24.65 to reflect a higher share count. Add retained.

Sector: Health Care Equipment & Services.

Target price is $24.58.Current Price is $21.00. Difference: $3.58 - (brackets indicate current price is over target). If EBO meets the Morgans target it will return approximately 15% (excluding dividends, fees and charges - negative figures indicate an expected loss).

© 2020 Acquisdata Pty Ltd., source FN Arena